Enliven Therapeutics (NASDAQ:ELVN) Insider Joseph Lyssikatos Sells 1,500 Shares
MarketBeat
Enliven Therapeutics, Inc. (NASDAQ:ELVN - Get Free Report) insider Joseph Lyssikatos sold 1,500 shares of the firm's stock in a transaction on Tuesday, September 23rd. The shares were sold at an average price of $20.03, for a total value of $30,045.00. Following the transaction, the insider directly owned 931,688 shares of the company's stock, valued at $18,661,710.64. This represents a 0.16% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.
NASDAQ:ELVN
